As of 2025-10-15, the Relative Valuation of Albireo Pharma Inc (ALBO) is (54.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -222.8%.
The range of the Relative Valuation is (42.86) - (71.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.3x | 7.8x |
| Forward P/E multiples | 6.8x - 11.8x | 9.3x |
| Fair Price | (42.86) - (71.44) | (54.21) |
| Upside | -197.1% - -261.8% | -222.8% |
| Date | P/E |